Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 2/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | PRMT5 | O14744 | 3/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 3/20 | 0.32 |
| ▸ | TBK1 | Q9UHD2 | 2/20 | 0.32 |
| ▸ | ELANE | P08246 | 2/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.31 |
| ▸ | PDE2A | O00408 | 1/20 | 0.30 |
| ▸ | PDE1A | P54750 | 1/20 | 0.30 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.30 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.30 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.30 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21758257 | 0.95 | ABL1 (0.34) | ABL1CYP11B1CYP11B2PRKCQNR3C1 | |
| SCHEMBL21758249 | 0.90 | ABL1 (0.36) | ABL1CYP11B1CYP11B2NR3C1TBK1 | |
| SCHEMBL21758576 | 0.90 | ELANE (0.35) | ABL1ELANESLC22A12PDE3BPDE3A | |
| SCHEMBL21132058 | 0.88 | AR (0.35) | PRKCQNR3C1PRMT5WDR77TBK1 | |
| SCHEMBL21758611 | 0.87 | AR (0.38) | ABL1CYP11B1CYP11B2NR3C1 | |
| SCHEMBL21758246 | 0.86 | ABL1 (0.33) | ABL1CYP11B1CYP11B2NR3C1ELANE | |
| SCHEMBL21758599 | 0.86 | NPY5R (0.34) | CYP11B1CYP11B2NR3C1PRMT5WDR77 | |
| SCHEMBL21758575 | 0.85 | SLC22A12 (0.35) | ELANESLC22A12 | |
| SCHEMBL21758252 | 0.85 | NR3C1 (0.43) | CYP11B1CYP11B2NR3C1 | |
| SCHEMBL21758623 | 0.84 | CYP11B1 (0.38) | CYP11B1CYP11B2NR3C1PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062734-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OXER1, OR10J3, OXGR1 | ABL1 2452/4885CYP11B1 1224/4885CYP11B2 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.